Efficacy of natalizumab in second line therapy of relapsing–remitting multiple sclerosis: results from a multi‐center study in German speaking countries
Identifieur interne : 000322 ( Istex/Checkpoint ); précédent : 000321; suivant : 000323Efficacy of natalizumab in second line therapy of relapsing–remitting multiple sclerosis: results from a multi‐center study in German speaking countries
Auteurs : N. Putzki [Allemagne, Suisse] ; O. Yaldizli [Suisse] ; M. M Urer [Allemagne] ; S. Cursiefen [Allemagne] ; S. Kuckert [Allemagne] ; C. Klawe [Allemagne] ; M. Maschke [Allemagne] ; B. Tettenborn [Suisse] ; V. Limmroth [Allemagne]Source :
- European Journal of Neurology [ 1351-5101 ] ; 2010-01.
English descriptors
Abstract
Background: Natalizumab has been recommended for the treatment of relapsing–remitting multiple sclerosis (RRMS) in patients with insufficient response to interferon‐beta/glatiramer acetate (DMT) or aggressive MS. The pivotal trials were not conducted to investigate natalizumab monotherapy in this patient population.
Url:
DOI: 10.1111/j.1468-1331.2009.02728.x
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
ISTEX:D7EFE7528A83DCB4231262DC63949199D5BB7990Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Efficacy of natalizumab in second line therapy of relapsing–remitting multiple sclerosis: results from a multi‐center study in German speaking countries</title><author><name sortKey="Putzki, N" sort="Putzki, N" uniqKey="Putzki N" first="N." last="Putzki">N. Putzki</name></author><author><name sortKey="Yaldizli, O" sort="Yaldizli, O" uniqKey="Yaldizli O" first="O." last="Yaldizli">O. Yaldizli</name></author><author><name sortKey="M Urer, M" sort="M Urer, M" uniqKey="M Urer M" first="M." last="M Urer">M. M Urer</name></author><author><name sortKey="Cursiefen, S" sort="Cursiefen, S" uniqKey="Cursiefen S" first="S." last="Cursiefen">S. Cursiefen</name></author><author><name sortKey="Kuckert, S" sort="Kuckert, S" uniqKey="Kuckert S" first="S." last="Kuckert">S. Kuckert</name></author><author><name sortKey="Klawe, C" sort="Klawe, C" uniqKey="Klawe C" first="C." last="Klawe">C. Klawe</name></author><author><name sortKey="Maschke, M" sort="Maschke, M" uniqKey="Maschke M" first="M." last="Maschke">M. Maschke</name></author><author><name sortKey="Tettenborn, B" sort="Tettenborn, B" uniqKey="Tettenborn B" first="B." last="Tettenborn">B. Tettenborn</name></author><author><name sortKey="Limmroth, V" sort="Limmroth, V" uniqKey="Limmroth V" first="V." last="Limmroth">V. Limmroth</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:D7EFE7528A83DCB4231262DC63949199D5BB7990</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1111/j.1468-1331.2009.02728.x</idno><idno type="url">https://api.istex.fr/document/D7EFE7528A83DCB4231262DC63949199D5BB7990/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000B08</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000B08</idno><idno type="wicri:Area/Istex/Curation">000A45</idno><idno type="wicri:Area/Istex/Checkpoint">000322</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000322</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Efficacy of natalizumab in second line therapy of relapsing–remitting multiple sclerosis: results from a multi‐center study in German speaking countries</title><author><name sortKey="Putzki, N" sort="Putzki, N" uniqKey="Putzki N" first="N." last="Putzki">N. Putzki</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, University Clinic Essen, University of Duisburg‐Essen</wicri:regionArea><wicri:noRegion>University of Duisburg‐Essen</wicri:noRegion><wicri:noRegion>University of Duisburg‐Essen</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Neurology, Cantonal Hospital St. Gallen, St Gallen</wicri:regionArea><wicri:noRegion>St Gallen</wicri:noRegion></affiliation></author><author><name sortKey="Yaldizli, O" sort="Yaldizli, O" uniqKey="Yaldizli O" first="O." last="Yaldizli">O. Yaldizli</name><affiliation wicri:level="1"><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Neurology, Cantonal Hospital St. Gallen, St Gallen</wicri:regionArea><wicri:noRegion>St Gallen</wicri:noRegion></affiliation></author><author><name sortKey="M Urer, M" sort="M Urer, M" uniqKey="M Urer M" first="M." last="M Urer">M. M Urer</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, University Clinic Erlangen, Erlangen</wicri:regionArea><placeName><settlement type="city">Erlangen</settlement><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Moyenne-Franconie</region></placeName></affiliation></author><author><name sortKey="Cursiefen, S" sort="Cursiefen, S" uniqKey="Cursiefen S" first="S." last="Cursiefen">S. Cursiefen</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, University Clinic Erlangen, Erlangen</wicri:regionArea><placeName><settlement type="city">Erlangen</settlement><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Moyenne-Franconie</region></placeName></affiliation></author><author><name sortKey="Kuckert, S" sort="Kuckert, S" uniqKey="Kuckert S" first="S." last="Kuckert">S. Kuckert</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, Cologne City Hospitals, Cologne‐Merheim</wicri:regionArea><wicri:noRegion>Cologne‐Merheim</wicri:noRegion><wicri:noRegion>Cologne‐Merheim</wicri:noRegion></affiliation></author><author><name sortKey="Klawe, C" sort="Klawe, C" uniqKey="Klawe C" first="C." last="Klawe">C. Klawe</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, Barmherzige Brueder Hospital, Trier</wicri:regionArea><wicri:noRegion>Trier</wicri:noRegion><wicri:noRegion>Trier</wicri:noRegion></affiliation></author><author><name sortKey="Maschke, M" sort="Maschke, M" uniqKey="Maschke M" first="M." last="Maschke">M. Maschke</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, Barmherzige Brueder Hospital, Trier</wicri:regionArea><wicri:noRegion>Trier</wicri:noRegion><wicri:noRegion>Trier</wicri:noRegion></affiliation></author><author><name sortKey="Tettenborn, B" sort="Tettenborn, B" uniqKey="Tettenborn B" first="B." last="Tettenborn">B. Tettenborn</name><affiliation wicri:level="1"><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Neurology, Cantonal Hospital St. Gallen, St Gallen</wicri:regionArea><wicri:noRegion>St Gallen</wicri:noRegion></affiliation></author><author><name sortKey="Limmroth, V" sort="Limmroth, V" uniqKey="Limmroth V" first="V." last="Limmroth">V. Limmroth</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, Cologne City Hospitals, Cologne‐Merheim</wicri:regionArea><wicri:noRegion>Cologne‐Merheim</wicri:noRegion><wicri:noRegion>Cologne‐Merheim</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">European Journal of Neurology</title><idno type="ISSN">1351-5101</idno><idno type="eISSN">1468-1331</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2010-01">2010-01</date><biblScope unit="volume">17</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="31">31</biblScope><biblScope unit="page" to="37">37</biblScope></imprint><idno type="ISSN">1351-5101</idno></series><idno type="istex">D7EFE7528A83DCB4231262DC63949199D5BB7990</idno><idno type="DOI">10.1111/j.1468-1331.2009.02728.x</idno><idno type="ArticleID">ENE2728</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1351-5101</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>disease modifying therapy</term><term>multiple sclerosis</term><term>natalizumab</term><term>treatment failure</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Background: Natalizumab has been recommended for the treatment of relapsing–remitting multiple sclerosis (RRMS) in patients with insufficient response to interferon‐beta/glatiramer acetate (DMT) or aggressive MS. The pivotal trials were not conducted to investigate natalizumab monotherapy in this patient population.</div></front></TEI><affiliations><list><country><li>Allemagne</li><li>Suisse</li></country><region><li>Bavière</li><li>District de Moyenne-Franconie</li></region><settlement><li>Erlangen</li></settlement></list><tree><country name="Allemagne"><noRegion><name sortKey="Putzki, N" sort="Putzki, N" uniqKey="Putzki N" first="N." last="Putzki">N. Putzki</name></noRegion><name sortKey="Cursiefen, S" sort="Cursiefen, S" uniqKey="Cursiefen S" first="S." last="Cursiefen">S. Cursiefen</name><name sortKey="Klawe, C" sort="Klawe, C" uniqKey="Klawe C" first="C." last="Klawe">C. Klawe</name><name sortKey="Kuckert, S" sort="Kuckert, S" uniqKey="Kuckert S" first="S." last="Kuckert">S. Kuckert</name><name sortKey="Limmroth, V" sort="Limmroth, V" uniqKey="Limmroth V" first="V." last="Limmroth">V. Limmroth</name><name sortKey="M Urer, M" sort="M Urer, M" uniqKey="M Urer M" first="M." last="M Urer">M. M Urer</name><name sortKey="Maschke, M" sort="Maschke, M" uniqKey="Maschke M" first="M." last="Maschke">M. Maschke</name></country><country name="Suisse"><noRegion><name sortKey="Putzki, N" sort="Putzki, N" uniqKey="Putzki N" first="N." last="Putzki">N. Putzki</name></noRegion><name sortKey="Tettenborn, B" sort="Tettenborn, B" uniqKey="Tettenborn B" first="B." last="Tettenborn">B. Tettenborn</name><name sortKey="Yaldizli, O" sort="Yaldizli, O" uniqKey="Yaldizli O" first="O." last="Yaldizli">O. Yaldizli</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Rhénanie/explor/UnivTrevesV1/Data/Istex/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000322 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd -nk 000322 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Rhénanie
|area= UnivTrevesV1
|flux= Istex
|étape= Checkpoint
|type= RBID
|clé= ISTEX:D7EFE7528A83DCB4231262DC63949199D5BB7990
|texte= Efficacy of natalizumab in second line therapy of relapsing–remitting multiple sclerosis: results from a multi‐center study in German speaking countries
}}
| This area was generated with Dilib version V0.6.31. |  |